Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
about
Immunoglobulin free light chains in saliva: a potential marker for disease activity in multiple sclerosis.Trajectories of disposable income among people of working ages diagnosed with multiple sclerosis: a nationwide register-based cohort study in Sweden 7 years before to 4 years after diagnosis with a population-based reference group.
P2860
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@en
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@nl
type
label
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@en
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@nl
prefLabel
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@en
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@nl
P2093
P2860
P356
P1476
Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.
@en
P2093
Elizabeth A Mills
Yang Mao-Draayer
P2860
P356
10.3389/FNEUR.2017.00116
P577
2017-03-29T00:00:00Z